Cargando…

Toll-like receptor activation enhances cell-mediated immunity induced by an antibody vaccine targeting human dendritic cells

Previously, we have successfully targeted the mannose receptor (MR) expressed on monocyte-derived dendritic cells (DCs) using a fully human MR-specific antibody, B11, as a vehicle to deliver whole protein tumor antigens such as the human chorionic gonadotropin hormone (hCGβ). Since MRs play a role i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ramakrishna, Venky, Vasilakos, John P, Tario, Joseph D, Berger, Marc A, Wallace, Paul K, Keler, Tibor
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794405/ https://www.ncbi.nlm.nih.gov/pubmed/17254349 http://dx.doi.org/10.1186/1479-5876-5-5

Ejemplares similares

Toll-like receptor agonists shape the immune responses to a mannose receptor-targeted cancer vaccine
por: He, Li-Zhen, et al.
Publicado: (2015)

Characterization of the human T cell response to in vitro CD27 costimulation with varlilumab
por: Ramakrishna, Venky, et al.
Publicado: (2015)

Natural toll-like receptor agonists in prophylactic vaccines for dendritic cell activation
por: Peng, Paul, et al.
Publicado: (2015)

Immune correlates of Varlilumab treated cancer patients are consistent with CD27 costimulatory activity
por: Bullock, Timothy, et al.
Publicado: (2014)

Targeting human CD27 with an agonist antibody stimulates T-cell activation and antitumor immunity
por: Thomas, Lawrence J, et al.
Publicado: (2014)

Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity
por: Vo, Manh-Cuong, et al.
Publicado: (2015)

Activation of Dendritic Cells by the Novel Toll-Like Receptor 3 Agonist RGC100
por: Naumann, Kai, et al.
Publicado: (2013)

Toll‐like receptors matter: plasmacytoid dendritic cells in COVID‐19
por: Becker, Jennifer, et al.
Publicado: (2022)

Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4
por: Termeer, Christian, et al.
Publicado: (2002)

Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy
por: Matsumoto, Misako, et al.
Publicado: (2017)

Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice
por: Wang, Bei, et al.
Publicado: (2012)

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands
por: Grossmann, Claudius, et al.
Publicado: (2009)

Regulation of Toll-like Receptor 5 Gene Expression and Function on Mucosal Dendritic Cells
por: Feng, Ting, et al.
Publicado: (2012)

Dysregulated Responsiveness of Circulating Dendritic Cells to Toll-Like Receptors in ANCA-Associated Vasculitis
por: Braudeau, Cécile, et al.
Publicado: (2017)

Subset-Specific Expression of Toll-Like Receptors by Bovine Afferent Lymph Dendritic Cells
por: Werling, Dirk, et al.
Publicado: (2017)

Effect of Pingchuan Formula on Toll-Like Receptors and Dendritic Cells in an Asthmatic Mouse Model
por: Liu, Fei, et al.
Publicado: (2020)

Circulating precursors of human CD1c(+) and CD141(+) dendritic cells
por: Breton, Gaëlle, et al.
Publicado: (2015)

Potent induction of antibody-secreting B-cells by human dermal-derived CD14+ dendritic cells triggered by dual toll-like receptor ligation
por: Matthews, K, et al.
Publicado: (2012)

Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation
por: Guiducci, Cristiana, et al.
Publicado: (2006)

Induction of hypoxia inducible factor 1α by Toll-like receptors in human dendritic cells
por: Djafarzadeh, S, et al.
Publicado: (2008)

Identification of Toll-Like Receptor 9 as Parapoxvirus Ovis-Sensing Receptor in Plasmacytoid Dendritic Cells
por: von Buttlar, Heiner, et al.
Publicado: (2014)

Neoagarohexaose-mediated activation of dendritic cells via Toll-like receptor 4 leads to stimulation of natural killer cells and enhancement of antitumor immunity
por: Lee, Moon Hee, et al.
Publicado: (2017)

Combination therapy targeting toll like receptors 7, 8 and 9 eliminates large established tumors
por: Zhao, By Gan, et al.
Publicado: (2014)

Inhibition of CD4+CD25+ Regulatory T Cell Function and Conversion into Th1-Like Effectors by a Toll-Like Receptor-Activated Dendritic Cell Vaccine
por: Lee, Major K., et al.
Publicado: (2013)

The role of Toll-like receptor-4 in pertussis vaccine-induced immunity
por: Banus, Sander, et al.
Publicado: (2008)

Toll-like receptors: the swiss army knife of immunity and vaccine development
por: Dowling, Jennifer K, et al.
Publicado: (2016)

Dendritic cell vaccination and immune monitoring
por: Aarntzen, E. H. J. G., et al.
Publicado: (2008)

Targeting Toll-like receptor signaling in plasmacytoid dendritic cells and autoreactive B cells as a therapy for lupus
por: Lenert, Petar S
Publicado: (2006)

Birch Pollen Induces Toll-Like Receptor 4-Dependent Dendritic Cell Activation Favoring T Cell Responses
por: Pointner, Lisa, et al.
Publicado: (2021)

A Role for Syntaxin 3 in the Secretion of IL-6 from Dendritic Cells Following Activation of Toll-Like Receptors
por: Collins, Laura E., et al.
Publicado: (2015)

Toll-like receptor 4 and Syk kinase shape dendritic cell-induced immune activation to major house dust mite allergens
por: Busold, Stefanie, et al.
Publicado: (2023)

Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes
por: Boulé, Melissa W., et al.
Publicado: (2004)

Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
por: Lund, Jennifer, et al.
Publicado: (2003)

Dual Role of the Tyrosine Kinase Syk in Regulation of Toll-Like Receptor Signaling in Plasmacytoid Dendritic Cells
por: Aouar, Besma, et al.
Publicado: (2016)

Bacterial Lipoteichoic Acid Attenuates Toll-Like Receptor Dependent Dendritic Cells Activation and Inflammatory Response
por: Saito, Suguru, et al.
Publicado: (2020)

Toll-like Receptor 9 Induced Dendritic Cell Activation Promotes Anti-Myeloperoxidase Autoimmunity and Glomerulonephritis
por: Ford, Sharon L., et al.
Publicado: (2023)

Efficiency of Interferon-γ in Activating Dendritic Cells and Its Potential Synergy with Toll-like Receptor Agonists
por: Bian, Yuanzhi, et al.
Publicado: (2023)

Innate immunity and Toll-like receptors
por: O'Neill, LAJ
Publicado: (2004)

The Novel Toll-Like Receptor 2 Agonist SUP3 Enhances Antigen Presentation and T Cell Activation by Dendritic Cells
por: Guo, Xueheng, et al.
Publicado: (2017)

Dyslipidemia inhibits Toll-like receptor–induced activation of CD8α-negative dendritic cells and protective Th1 type immunity
por: Shamshiev, Abdijapar T., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_eirvpud1l8ck30m3db95upe74a